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Short text for Table of Content 
The progress achieved in the area of enantioseparation processes is reviewed focusing on 
enantioselective crystallization and preparative chromatography applied both individually or 
coupled. The incorporation of racemization steps is also considered. 
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The provision of pure enantiomers is of increasing importance not only for the 
pharmaceutical industry but also for agrochemistry and in biotechnology. In general 
there are two rivaling approaches to provide pure enantiomers. The chiral approach is 
based on developing an asymmetric synthesis of just one of the enantiomers. In 
contrast, the racemic approach is based on separating mixtures of the two enantiomers. 
In the last years remarkable progress has been achieved in the latter area. Below a 
review is given focusing in particular on enantioselective crystallization processes and 
preparative chromatography, including also hybrid processes and the incorporation of 
racemization steps. For illustration serve several examples studied in the laboratory of 
the authors. The manuscript illustrates the large potential for improved provision of pure 
enantiomers by joint efforts of synthesis chemistry and separation science. 
 
1. Introduction 
Enantiomers are stereoisomers that are non-superimposable mirror images of each other. They 
are designated by classical notations as (D) or (L), as (R) or (S) or as (+) or (-).[e.g. 1] There is still 
no final answer to the question, why life is essentially constructed using L-amino acids as 
building blocks. This fascinating and unsolved problem continues to stimulate a large spectrum 
of research activities.[e.g. 2-5] Independent of the outcome, there is a tremendous interest to 
produce pure enantiomers in the food and agrochemical industries, and in particular in the 
pharmaceutical industry.[6-8] Nowadays, there is clear evidence that in chiral drugs often only 
one enantiomer provides the desired physiological effect. In many cases, the other enantiomer 
has no effect or is even harmful. Regulators increasingly demand that chiral drugs are 
administered in optically pure form.[9-11] This has intensified efforts of industrial and academic 
research devoted to develop techniques which are capable to produce pure enantiomers. The 
approaches applied can be divided into: A) the “chiral approach” based on developing an 
asymmetric synthesis of just one of the enantiomers or B) the “racemic approach” based on 
separating mixtures of the two enantiomers.[12-14] 
In the last years remarkable progress has been achieved in the field of asymmetric synthesis 
(often also called enantioselective synthesis or stereoselective synthesis) applying essentially 
the four main concepts indicated in Fig. 1 and described shortly below. 
 
Fermentation methods 
Methods based on exploiting the selective natural metabolism of microorganisms are applied 
very successfully in a very large scale to produce optically pure amino acids, in particular as 
food additives. E.g. the production of L-Lysine by fermentation is realized exploiting genetically 
adapted cell lines of Corynebacterium glutamicum. There are many excellent reviews available 
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describing both the mechanisms of various successful biotransformations and related industrial 
applications.[15] 
 
Chiral pool synthesis 
In this easiest approach available chiral starting materials are manipulated through successive 
reactions using achiral reagents retaining chirality to obtain desired target molecules. This 
concept is especially attractive for target molecules having a chirality similar to a relatively 
inexpensive naturally occurring building block, such as e.g. a sugar or an amino acid. However, 
the number of possible reactions the molecules can undergo is restricted, and tortuous synthetic 
routes may be required. This approach requires stoichiometric amounts of suitable starting 




Figure 1: Illustration of possible pathways leading to pure enantiomers. 
 
Use of chiral auxiliaries 
What many strategies in asymmetric synthesis have in common is asymmetric induction to 
transform enantiomers into diastereomers, which have different reactivities. One asymmetric 
induction strategy is e.g. the use of a chiral auxiliary to form an adduct with the starting material 
which leaves only the desired trajectory open and physically blocks the other one. Assuming the 
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chiral auxiliary is enantiopure, the different reaction path ways are not equivalent and lead to 
different products. The application of the concept requires one reaction step to add and another 
one to remove the auxiliary, which typically increases costs and decreases yields.[17] 
 
Asymmetric catalysis 
Small amounts of chiral enantiomerically pure (or just optically active) catalysts can promote 
desired reactions and lead to the formation of larger amounts of enantiomerically pure or 
enriched products.[18-20] Currently three different kinds of chiral catalysts are mostly employed: 
• metal ligand complexes derived from chiral ligands 
• chiral organocatalysts and 
• biocatalysts (enzymatic processes) 
The first methods were pioneered by William S. Knowles and Ryoji Noyori (Nobel Prize in 
Chemistry 2001) and Henri Kagan. Knowles replaced in 1968 the achiral triphenylphosphine 
ligands in Wilkinson's catalyst by the chiral phosphine ligands P(Ph)(Me)(Propyl) and created a 
first asymmetric catalyst[21, 22] , which was employed in an asymmetric hydrogenation resulting in 
an enantiomeric excess of 15%. The methodology was ultimately used in an asymmetric 
hydrogenation step in the industrial production of L-DOPA. In the same year Noyori[23] published 
his chiral ligand for a cyclopropanation reaction of styrene. In common with the observations 
Knowles made, the enantiomeric excess for this first generation ligand was with 6% still 
disappointingly low. A major breakthrough was achieved by Kagan in 1971/1972 developing a 
very effective chiral bidentate diphosphine ligand.[24] 
Examples of successful applications of asymmetric catalysis include: 
• applications of the chiral phosphine BINAP in combination with ruthenium or rhodium 
compounds (these complexes catalyze well the hydrogenation of functionalized alkenes 
on only one face of the molecule, a corresponding process developed by Noyori for the 
synthesis of menthol using a chiral BINAP-rhodium complex is commercialized[25]), 
• the synthesis of Naproxen with a chiral phosphine ligand in a hydrocyanation reac-
tion,[26] 
• reactions of an alkene with osmium tetroxide in the presence of a chiral quinine ligand to 
form a vicinaldiol (Sharpless dihydroxylation and aminohydroxylation).[27] 
There are excellent reviews available summarizing the progess achieved in the fields of 
enantioselective organocatalysis[28]. Comprehensive overviews regarding the current status of 
asymmetric catalysis including also fermentation and biocatalysis give.[29,30] Various examples of 
successful industrial application are described. In some cases combinations of all three catalytic 




Nonselective synthesis and resolution of racemates 
Considering the broad spectrum of desired target molecules, despite of tremendous progress 
achieved in the last decades, the number of highly selective reactions supplying pure 
enantiomers in industrially relevant scales is still limited. Consequently, there is a large interest 
in developing and using cheap, reliable and widely applicable enantioselective separation 
processes. 
In this review we will discuss the current status of the most successful enantiomer separation 
techniques. Hereby the focus is set on techniques which could be applied in a preparative and 
industrial scale, i.e. the large arsenal of techniques developed for analytical purposes is not 
considered. The latter aspect is extensively discussed in various reviews and textbooks 
focusing mostly on analytical chromatography and electrophoresis.[31-33] 
After shortly introducing in the next section important concepts which allow performing 
separations of enantiomers, a particular focus will be set on selective crystallization and 
chromatographic methods. Significant progress has been achieved regarding these two 
methods and they are currently seen as the most flexible and productive ones. Various 
concepts will be illustrated using examples of separations performed in our laboratory. Finally, 
promising new process variants based on coupling different separation principles and the 
inclusion of racemization steps will be discussed, presenting results of joint work carried out 
recently within the European project “INTENANT”.[34] 
 
2. Techniques capable to separate enantiomers 
Due to their importance and difficulty the separation of enantiomers has been studied 
intensively in the last decades. Comprehensive overviews were given recently[35-39] and excellent 
descriptions of selected process concepts are available.[e.g. 31, 40] 
Usually the provision of an initial asymmetry is needed to permit enantioseparation. In the 
various separation methods developed this is provided by specific chiral partners, which could 
be e.g. reactants, solvents, carriers or solid surfaces. If available, also some of the target 
enantiomers could be initially invested to recover later in increased amounts. The methods 
developed differ essentially in the types of chiral partner used and the phase situations present 
during the separation process. 
Before we will concentrate in more detail on the currently most promising enantioseparation 
methods, namely crystallization and chromatography, we describe below briefly the principle 
and status of other important resolution methods. 
 
Kinetic and dynamic kinetic resolution 
Kinetic resolution exploits the difference in the consumption rates of two enantiomers in a 
chemical reaction. Based on this difference an excess of the less reactive enantiomer is 
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created, which goes through a maximum before it disappears on full completion of the reaction. 
Kinetic resolution is a very old concept in organic chemistry and was used successfully in the 
organic synthesis of various chiral molecules. It was first observed by Marckwald and McKenzie 
in 1899 in the esterification reaction of racemic mandelic acid with optically active (-)-menthol to 
a pair of diastereomeric esters.[41]In this reaction the (R)-enantiomer of mandelic acid displays 
the higher reaction rate and, with incomplete conversion, the reaction mixture becomes 
enriched in (S)-mandelic acid. Full hydrolysis of the incomplete esterification mixture gives an 
excess of (R)-mandelic acid. Taking the reaction to 100% completion will again produce equal 
amounts of both esters. 
An important extension of kinetic resolution is called dynamic kinetic resolution (DKR). It tackles 
the obvious drawbacks of the above-described system, namely that the maximum conversion in 
the reaction is only 50% and the product has to be separated from the reactants. In DKR, it is 
possible to convert the achiral reactant with 100% completion because both enantiomers 
engage in a chemical equilibrium and exchange. In this way, the faster-reacting enantiomer is 
replenished in the course of the reaction at the expense of the slower-reacting enantiomer. One 
of the earliest demonstrations of this method is an adaptation of the Noyori asymmetric 
hydrogenation.[42, 43] 
The principle of DKR is used successfully applying both enzymatic and chemical reactions. 
Several examples of enzymatic DKR processes are given in [44]. An overview on nonenzymatic 
kinetic resolution is provided in.[45] 
The combination of kinetic resolution in ionic liquids (IL) and selective extraction with 
supercritical carbon dioxide (scCO2) provides a new approach for the separation of 
enantiomers as exemplified by the lipase-catalyzed esterification of chiral secondary alcohols.[46] 
The need to identify suitable reaction partners and the typically high requirements regarding 
product purity still restrict wider application of the attractive kinetic resolution approach. 
 
Enantioselective liquid-liquid extraction 
In general liquid-liquid extraction is a mature separation method that can be operated in a 
productive countercurrent mode to fractionate continuously racemates into their enantiomers.[47] 
Enantioselective liquid-liquid extraction (ELLE) is closely affiliated to the large field of host-guest 
chemistry.[48] It combines the concepts of enantiomeric recognition and solvent extraction in a 
single technique. The possibility to operate at different scales makes the use of liquid-liquid 
extraction interesting for enantioseparation.  
There are many reports about successful enantioselective liquid-liquid extractions in a 
laboratory scale. Most of these studies deal with the identification and characterization of 
extraction systems. Hereby the most frequently used carriers are cyclodextrin derivatives,[e.g. 49] 
tartaric acid derivatives[e.g. 50, 51] and crown ethers.[e.g. 52] Metal complexes and metalloids have 
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been also applied successfully as reactive extractants.[53, 54] The resolution of racemic N-benzyl-
α–amino acids using a chiral cobalt (III) salen complex was studied in[55]. Recently, successful 
attempts were reported combining the effects of two carriers.[56] A review regarding 
technological aspects was given in[57]. 
The development of efficient processes requires multistage schemes with back-extraction 
sections to recover the host. Many types of extraction columns are available with a broad range 
of internals to enhance mass transport and facilitate separation. Numerous types of centrifugal 
extractors have been developed. The first device that was especially designed for ELLE 
purposes was the chiral resolution machine developed by Cram and coworkers.[58] A novel more 
advanced Centrifugal Contactor Separator was introduced recently.[59] The application of a 
related concept designated as continuous countercurrent chromatography is described in[60]. 
Overviews regarding enantioselective liquid-liquid extraction were given recently in[61, 62]. 
Broader commercialization of ELLE has not been achieved to date. Currently the selectivities 
achieved are typically still below 1.2, whereas for successful applications a minimum selectivity 
of 1.5 is desired in order to limit the number of extraction stages required. To promote industrial 
applications, easily accessible hosts with a high selectivity towards a wider substrate spectrum 
are required to reduce the time for developing the separation processes. 
 
Application of membranes 
 
Another strategy to separate enantiomers is based on the use of membrane-based approaches. 
Examples and overviews introducing different possibilities are given in[63-65]. Membrane 
separations offer, in general, attractive options for clean, energy efficient, easy to perform and 
continuous operation. 
Two basic types of membrane processes can be distinguished for the separation of racemic 
mixtures: a direct separation using enantioselective chiral membranes or a separation in which 
a non-enantioselective membrane assists in an enantioselective process. 
Chiral membranes can be liquids or dense polymers. In the former case the membrane liquid 
can be chiral or may contain a chiral additive (carrier). Often the membrane liquid is not used as 
a bulk phase but rather immobilized by capillary and interfacial tension forces in a porous matrix 
(supported liquid membrane).[66, 67] An interesting concept suggested is based on a combination 
of countercurrent fractionation and liquid membrane technology and applies two liquids, which 
are oppositely chiralized by the addition of the (R)- or the (S)-enantiomer of a chiral selector and 
separated by another non-miscible liquid immobilized in a porous membrane.[68]A main 
disadvantage of liquid membrane systems is their instability over longer periods of time.[69] 
Enantioselective solid polymer membranes typically consist of a nonselective porous support 
coated with a thin layer of an enantioselective selector. Various examples using different 
selectors and supports were suggested.[e.g. 70-73] Alternatively, molecularly imprinted polymers, 
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i.e. polymers having enantiospecific cavities in their bulk phase, have been suggested as a 
basis for chiral membranes. During the polymer synthesis one of the enantiomers is used as a 
template.[74] A detailed characterization of enantioselective membranes applying various L-
proline derivates as chiral carriers was given in.[75] 
Regarding the application of nonselective achiral membranes there is significant progress in 
applying cheap and widely accessible ultrafiltration membranes. The selectivity is achieved by 
preferably creating in the feed phase micelles or complexes with enzymes formed with only one 
of the enantiomers. Then the separation is simply based on retaining the larger complexes and 
allowing permeation of the unbound enantiomer.[76-78] 
In order to reach high purities, due to the limited separation factors, membrane processes have 
to be carried out typically in several stages.[79] General drawbacks of membrane technology, 
limiting currently the application potential, are the relatively low transport rates through the 
membranes and the risk of membrane fouling. 
 
Other resolution techniques 
An overview regarding other, less frequently studied and not so far developed chiral resolution 
concepts is given in[35,36]. Introduced are e.g. enantioselective foam flotation, preparative gel 
electrophoresis and distillation. Enantioselective distillation is discussed e.g. in[80]. However, all 
techniques mentioned and other alternatives have not yet acquired larger industrial relevance. 
In the next two main sections of this paper we will concentrate in more detail on 
enantioselective crystallization and chromatography. Hereby, mainly examples of separations 
carried out in our laboratory will be used for illustration. 
 
3. Crystallization-based methods to separate enantiomers 
Since Pasteur’s famous experiments of separating the sodium ammonium tartrate enantiomers 
by direct crystallization,[81] extensive activities have been devoted to study and to apply 
crystallization processes for enantioseparation purposes. Substantial progress has been 
achieved both in understanding the thermodynamic and kinetic fundamentals behind 
enantioselective crystallization and also in exploiting this knowledge for the development of 
suitable crystallization methods. In general, crystallization techniques have the advantage of 
being widely applicable, simple and cost-efficient. To carry out crystallization, just standard 
equipment is required which is readily available in the pharmaceutical and fine chemical 
industries. Crystallization techniques are not restricted to resolution of racemates but can also 
be applied for further purification of non-racemic mixtures of enantiomers resulting from other 
techniques such as partially selective synthesis, chromatographic or membrane separation. 
Compared to asymmetric synthesis and chromatographic separations, crystallization processes 
often bear a “low-tech-image” or are considered sometimes as “out-of-date technology”. 
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Though, when reviewing manufacturing methods applied to provide pure enantiomer drugs, it 
becomes obvious that the majority of drugs are produced via classical resolution, i.e. 
crystallization.[39] An overview on crystallization methods for resolution of racemates is given in 
the textbook of Jacques and coworkers.[82] A review on current patents in the field of optical 
resolution by crystallization methods with focus on amino acids has been published recently.[83] 
In principle, Pasteur’s technique of hand sorting crystals of the two enantiomers is still a feasible 
technique to separate racemic conglomerates that show enantiomorphism.[82] However, 
provided that crystals with well-defined morphological characteristics can be produced, a 
broader, in particular industrial application would require reliable methods for automatic shape 
recognition and solid-solid separation. The challenging task of developing such methods might 
be subject of future activities. 
 
Classical resolution 
In classical resolution the racemate to be resolved is converted with a suitable enantiomerically 
pure resolving agent to provide two diastereomeric salts which have different solubilities and, 
thus, are separable by crystallization. This technique has the advantage of being robust and 
simple to operate. However, without additional efforts to incorporate racemization the 
achievable yields are limited to 50%. Classical resolution is still the most frequently applied 
technology for enantioseparation at industrial scale and increasingly also the method of choice 
in the API section.[39] E.g., thousands of tons per year of (S)-naproxen, D-phenylglycine and D-4-
hydroxyphenylglycine are produced via the formation and separation of diastereomeric salts, as 
reported in a “Highlights” article in Angew. Chem. Int. Ed. in 1998.[84] More recently launched 
drugs produced via classical resolution are Frovatriptan (2002), Duloxetine and Eszopiclone 
(both 2004).[39] 
When racemization of the unwanted enantiomer is feasible, the low yield inherent in a 
diastereomeric resolution can be overcome offering significant increases in product amount and 
thus, process performance. Exemplarily, it is reported that implementing chemical racemization 
within the (S)-naproxen production can enhance the overall yield to ≥95%.[85] A more recent 
example of a so-called crystallization-induced diastereomeric transformation refers to the API 
Sertraline where a semi-continuous resolution-racemization process is performed.[86] Most 
frequently used acidic and basic resolving agents are natural L-tartaric acid, its derivatives such 
as L-/D-dibenzoyl- and L-/D-ditolouyltartaric acid, (R)-/(S)-mandelic acid and (+)-/(-)-α-
methylbenzylamine.[39] The sometimes elaborate search for an optimal resolving agent that 
forms easily to separate diastereomeric salts with the compound to be resolved has clearly 
been improved by the introduction of a combinatorial approach.[87]Hereby, a family of resolving 
agents is simultaneously added to a solution of a racemate causing a rapid precipitation of a 
crystalline diastereomeric salt with high purity and yield. Since up to now the mechanism behind 
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this so-called “Dutch resolution” is not fully understood, work is directed to study its 
thermodynamic and kinetic origins.[88] A compilation of new developments in crystallization-
induced resolution focusing on Dutch resolution and examples of crystallization-induced 
asymmetric transformation (i.e. combination of classical resolution with in situ racemization) was 
published recently in a book contribution.[89] Novel aspects that should be mentioned here refer 
to the addition of achiral compounds with similar chemical structures (achiral additives) to the 
resolving agents which act as “catalysts” and thus affect the rate as well as the efficiency of the 
resolution process[90]. 
Broader reviews on classical resolution are given in[82, 91, 92]. Suggestions for the conceptual 
design of enantioselective crystallization processes implementing classical resolution and other 
alternatives are provided in [93]. 
 
Preferential crystallization of conglomerates 
Direct crystallization of an enantiomer from a racemic solution is only feasible in case that the 
enantiomers in their mixtures form separate but pure crystals and, thus, the corresponding 
racemates are just conglomerates, i.e. mixtures of crystals of both enantiomers. However, only 
5 to 10% of the chiral substances belong to this group of conglomerates.[94] For racemates of 
such substances preferential crystallization is an attractive technology that allows for direct 
crystallization of the desired enantiomer without needing any chiral auxiliary. Generally it can be 
distinguished between two techniques of direct crystallization, a) the entrainment process and 
b) simultaneous crystallization, both applicable to solution and melt phases. In the first case, the 
enantiomers crystallize consecutively from a supersaturated racemic solution and the process is 
not allowed to reach equilibrium. Actually, it is a kinetically driven separation relying on different 
crystallization rates of the enantiomers in presence of homochiral seeds. The entrainment 
process is usually applied at smaller scales in a batch mode. Examples of industrial use refer 
particularly to the production of broad-spectrum antibiotics such as chloramphenicol, 
thiamphenicol and β-lactames.[94] For larger scales the second type, i.e. simultaneous 
crystallization, is an option. There the enantiomers crystallize simultaneously but locally 
separated from a solution which always remains close to the racemic composition. The process 
can be performed both in batch and continuous mode and has been industrially realized e.g. for 
the production of (-)-menthol (via the benzylester, Haarmann & Reimer, 1400 t a-1) and an L-α-
methyldopa intermediate (Merck, >100 t a-1). Further, over a period of ten years Ajinomoto 
produced L-glutamic acid at about 13000 t a-1 by simultaneous crystallization.[82] From an 
industrial perspective, the design and features of continuous resolution processes using 
different configurations of stirred tank and fluidized bed systems were described in a 
monography published in 2009.[95] There, in particular the application of fluidized bed 
crystallizers and the implementation of ultrasonic cleavage of seed particles to maintain the 
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population balance are emphasized. Also very recently, the advantages of preferential 
crystallization were proven for resolving racemic calcium pantothenate (with the (R)-enantiomer 
an important commercial precursor of vitamin B5) and an industrially required resolving agent, 
both in lab and technical scale (35 L and 35 L) reaching high yields.[96, 97] 
Detailed information on preferential crystallization can be found in several overview 
articles[e.g. 94, 98] and book contributions.[82, 99] Capabilities and limitations (“pitfalls and rewards”) 
have just been highlighted in an article by Levilain and Coquerel.[100] 
Understanding the phenomenon of conglomerate formation also referred to as spontaneous 
resolution of racemates upon crystallization is reported to be “one of the great challenges in 
stererochemistry”[101] and several review articles are devoted to that issue.[e.g. 101, 102] Efforts to 
systematically derive possible conglomerates among a group of derivatives of a chiral 
substance of interest were described by the group of Bredikhin.[e.g. 103, 104] Recently, the usage of 
the Second Harmonic Generation effect has been proven as an alternative and efficient 
prescreening technique for detection of conglomerates[105]. Studies on the application of so-
called “tailor-made” additives to selectively inhibit the crystallization of the undesired enantiomer 
and, thus, to make the separation more robust have been performed in particular by the group 
of Lahav and Leiserowitz.[e.g. 106-108] In a recent work[109] the authors describe a cyclic separation 
process in the presence of a tailor-made single-enantiomer polymer that causes differences in 
growth and dissolution between the enantiomers and thus assists in resolution. 
In the last years different innovative process modifications have been suggested in order to 
enhance the performance of the classical isothermal process. These include amongst others 
polythermal crystallization procedures, auto-seeding strategies and innovative reactor 
concepts.[99, 110-117] Selected applications of preferential crystallization will be presented and 
discussed in chapter 3.3 below. There, advanced process concepts such as an auto-seeded 
polythermal process mode, first introduced by Coquerel and coworkers,[118] innovative 
crystallizer configurations and the extension of applying preferential crystallization to racemic 
compounds in integrated process schemes will be addressed. With regard to the latter, the 
ability of tailor-made (“molecularly” designed) additives to selectively inhibit the crystallization of 
the racemic compound and, accordingly, to support enantioselective crystallization in such 
systems was studied and reported.[119, 120] Further noteworthy work refers to enhancing yields in 
preferential crystallization by increasing the racemic mixture solubility via addition of appropriate 
modifiers.[121] 
Combination of preferential crystallization with racemization permits transformation of the 
unwanted enantiomer and thus, an increase in overall yield that is for preferential crystallization 
alone (as for classical resolution) inherently limited to 50%. Examples of implementing 
razemization procedures are given e.g. in [96, 122]. 
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Attrition-enhanced deracemization (Viedma ripening). Attrition-enhanced deracemization is 
a just recently emerged technique based on pathbreaking work of Viedma[123] who discovered 
that a 1:1 mixture of enantiomorphous NaClO3 crystals in contact with a saturated solution 
“deracemizes” when grinding the crystals in the suspension. This technique could be verified to 
be applicable in cases where the racemic substance to be resolved is 1) a conglomerate and 2) 
quickly racemizes in liquid state.[124] Just recently, the driving mechanism behind attrition-
enhanced deracemization[125, 126], novel application-related aspects[127, 128] and a first proof of its 
practical feasibility for a drug (Clopidogrel) intermediate have been reported.[129] Further it could 
be shown, that implementation of grinding and in-situ racemization in preferential crystallization 
facilitates an improved process performance with respect to yield and productivity.[130] 
The more general exploitation of Viedma ripening as well as the extension of applicability of 
preferential crystallization to racemic compounds are expected to increase the attractiveness of 
both techniques for industrial scale enantiomer separation. 
 
Optically active solvents 
A further method for resolution of racemates is the application of optically active solvents which 
might also be achiral solvents containing definite amounts of a pure enantiomer as solute. In 
principle, diastereomeric interactions can occur when enantiomers are dissolved in an optically 
active solvent. As a result these diastereomeric complexes should possess different physico-
chemical properties that might lead to differences in the solubility of the two enantiomers of the 
chiral substance to be resolved and, thus, should introduce a certain asymmetry in the 
appropriate solubility phase diagram. However, despite the fact that this concept has been 
considered as a relevant tool of enantioseparation since the beginning of the 20th century, only a 
few studies are reported[82] and there is a lack of systematic studies allowing for generalizable 
results. 
On the other hand, a couple of successful chiral resolutions employing kinetic effects for 
enantioselective crystallization with the help of optically active solvents have been described. 
For example, the resolution of racemic glutamic acid using a chiral solvent made from lysine 
and water was demonstrated.[131] Small amounts of L- or D-lysine were applied to retard the 
crystallization rate of the corresponding glutamic acid enantiomer leading to a transient optical 
resolution during crystallization. Additionally, successful chiral resolutions of some racemic 
conglomerates using the chiral solvents D-isopropyl tartrate and (-)-α-pinene were 
reported.[132, 133] This direct crystallization was feasible due to different rates of nucleation and/or 
growth of the two enantiomers. The resolution of a racemic compound in (-)-α-pinene was not 
successful.[133] Further work has been done by applying tailor-made additives in kinetic 
resolutions as already mentioned above (e.g. [106] or more recently [134]). All examples given only 
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apply to conglomerate systems. Comprehensive studies performed in our group were devoted 
to evaluate both thermodynamic and kinetic effects of chiral solvents on enantioselective 
crystallization. Specifically chosen solvents were applied also to verify the feasibility of resolving 
racemic compounds.[135-138] Selected results will be depicted in more detail in chapter 3.3.2. 
 
3.1 Solid-liquid equilibria and related possibilities for enantioseparation 
The application of crystallization for separation or purification of enantiomers requires a 
comprehensive knowledge of the fundamental solid-liquid equilibria (SLE) which form the 
thermodynamic basis of all crystallization processes. SLE data are graphically represented in 
phase diagrams which depict the equilibria between solid and liquid phases for a specific 
system in a wide range of temperatures and compositions. These phase diagrams specify the 
equilibrium conditions and the corresponding phases present in this state. Thus, they provide 
information about the identity of the solid phases involved such as polymorphs, solvates or solid 
solutions. The phase diagrams relevant with regard to crystallization-based enantioseparation 
are 1) the binary melt phase diagram of the two enantiomers describing the melting behavior in 
the binary system and 2) the ternary solubility phase diagram of the two enantiomers in a 
specific solvent depicting the solubility behavior of the enantiomers and their mixtures in 
presence of this solvent. Overviews regarding identified types of phase diagrams and their 
description have been published elsewhere.[82,94,139,140] Examples for systematic studies of 
binary and ternary phase diagrams are given in articles from the groups of Grant [e.g. 141] and 
Klussmann.[142, 143] To the knowledge of the authors, up to now there is no monograph available 
focusing mainly on phase equilibria of organic compounds. A comprehensive overview to the 
structure and characterization of molecular crystals and the formation of solid solutions in 
general can be found in the excellent books of Kitaigorodski.[144, 145] 
The fundamental types of phase diagrams occurring in chiral systems are schematically shown 
in Fig. 2.[146] Generally, since the enantiomers exhibit identical physical properties as melting 
points, melting enthalpies and solubilities, both the binary melt phase diagrams and the ternary 
solubility phase diagrams (upper and lower parts of Fig. 2, resp.) are symmetrical with respect 
to the racemic composition. This simplifies the determination of SLE for such systems, since just 
one half of the phase diagram has to be measured. 
Basically, one can distinguish between three main types of phase diagrams that arise from the 
particular characteristics of the crystalline racemate in the system and which have been firstly 
described in a pioneering work by Roozeboom.[140] In the 1st case, a simple eutectic is formed 
between the enantiomers at the racemic composition. Here, mixtures of the two enantiomers 
are just mechanical mixtures of crystals formed by homochiral molecules (conglomerates). 
Thus, in the racemic mixture the enantiomers form separate solid phases that may crystallize 
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separately, what is the main requirement for preferential crystallization. However, as already 
mentioned, just 5 to 10% of the chiral substances belong to that group.[94]  
 
 
Figure 2: Fundamental types of binary melt phase diagrams and ternary solubility phase diagrams for chiral 
systems. The latter are represented as isothermal slices depicting the SLE at a certain temperature, TI. 
Fat black lines mark related liquidus (saturation) lines. In the ternary phase diagram the eutectic 
composition in the chiral system is indicated by a dashed line connecting the solvent corner with the 
binary chiral system (“eutectic line”). In case of miscibility in the solid state (exemplified by the right 
triangle phase diagram) dotted tie-lines characterize the composition of the liquid and solid phases 
coexisting in equilibrium.(adopted from [146]) 
 
In the 2nd case, i.e. when the enantiomers form an intermediate stoichiometric 1:1 compound, 
there is only one solid phase present, the racemic compound. The majority of chiral systems 
(90-95%) form racemic compounds. Here, from a thermodynamic point of view, direct 
crystallization is not feasible to provide pure enantiomers from the racemates. An important 
property of such systems is the composition of the two eutectics occurring between the 
enantiomers and the racemic compound (mirror-shaped around the racemic composition). It will 
be shown later, that this composition essentially determines the crystallization techniques 
applicable to provide the desired pure enantiomer from enriched mixtures. 
In the 3rd case, complete miscibility at solid state occurs, i.e. the enantiomers form mixed 
crystals (solid solutions) at all compositions. The liquidus curve in the phase diagram can exhibit 
a melting point maximum, a melting point minimum or a constant melting temperature. The 
same applies to solubilities in the ternary phase diagram. It is clear from the tie-lines shown, 
that from an enriched solution no pure enantiomer can be crystallized. Therefore, this type of 
systems is the most unfavorable one for separation or purification purposes. Fractional 
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of phase diagram is very rare in case of molecular crystals in general and enantiomers in 
particular (<1%). Not considered in Fig. 2 is the fact, that partial miscibility in the solid state can 
occur for both conglomerates and racemic compound-forming systems. Related phase 
diagrams are sparsely reported. Examples referring to partial solid solutions on the enantiomer 
side are given in [147, 148], cases depicting limited miscibility at solid state for the racemic 
compound in [149] and examples with partial solid solutions for both the enantiomers and the 
racemate in [150]. 
The ternary solubility phase diagrams shown in Fig. 2 are isothermal cuts of the three-
dimensional representation of the ternary system of the two enantiomers and a solvent in an 
equilateral prism with temperature as vertical axis perpendicular to the prism base. Light grey 
areas represent the existence regions of the corresponding enantiomers, where in equilibrium 
these enantiomers as solid phases can be crystallized. The dark grey area relates to the 
existence region of the racemic compound, which is the solid phase crystallizing from solution 
compositions in this region. In the three-phase region embedded by the two-phase regions a 
pure enantiomer can only be crystallized under kinetically driven conditions. The “eutectic line” 
indicated must not necessarily be linear, it can also be curved. Examples will be shown below in 
chapter 3.3.2. Differing from the binary chiral systems, in the solubility phase diagrams solvates 
can occur as additional solid phases. For that reason and also since polymorphism might be 
solution-mediated (thus providing polymorphic varieties not revealed in the binary system) solid 
phase analysis should always accompany solubility measurements to avoid wrong allocation of 
solubility values to solid phases. 
Often the phase diagrams required are not known, in particular for newly synthesized 
substances. Frequently, one faces a lack of consistent solubility data for the substance of 
interest. Experimental determination is a tedious and time-consuming work and requires a 
sufficient amount of substance which is often not available in an early stage of development. In 
addition, usually a combination of different analytical techniques is necessary to obtain solubility 
values and to identify the solid phases in equilibrium with the saturated solution. Since ternary 
solubility diagrams are inherently closely related to the corresponding melt phase diagrams, 
preliminary determination of melt equilibria of the chiral system prior to the determination of 
solubility equilibria rationalizes the experimental efforts by specifying already the type of the 
crystalline racemate and the location of the eutectic composition in the chiral system. Moreover, 
based on the melting data (temperature and heat of fusion) ideal solubilities can be calculated 
providing a first rough estimate of the solubility curve using classical thermodynamic equations 
(simplified Schröder-van Laar equation).[82, 146] 
 
Possibilities of crystallization-based enantioseparation that arise from the ternary solubility 




Figure 3: General possibilities of crystallization-based enantioseparation without a chiral auxiliary illustrated for a) 
conglomerates and b) racemic compound-forming systems. The numbers and states of aggregation of 
the phases present in equilibrium are depicted in the particular regions (s: solid;l: liquid). 
 
If there are already enantiomerically enriched mixtures of the enantiomers available 
(characterized by a composition in the existence region of the pure enantiomer, e.g. dark grey 
points in Fig. 3), the target enantiomer can directly be crystallized. This so-called “classical 
enantioselective crystallization” is feasible for both conglomerates and racemic compound-
forming systems. 
Alternatively, one can work in the three-phase region of the phase diagram, where for 
conglomerates both enantiomers, and for racemic compound-forming systems one enantiomer 
and the racemic compound are present as solid phases in equilibrium. There, two options arise. 
1) If the initial solution contains the enantiomers close to the eutectic composition (e.g. light grey 
point in Fig. 3a), preferential crystallization can be applied. By adding seeds of just one 
enantiomer to a solution supersaturated with both antipodes, it is possible to selectively 
crystallize just the desired (seeded) enantiomer for a certain period of time. However, since in 
equilibrium both enantiomers are stable solid phases, this is a non-equilibrium kinetically driven 
process, where nucleation of the counter-enantiomer has to be avoided. As mentioned before, 
for resolution of racemates preferential crystallization is in principle only applicable to 
conglomerates. However, below it will be demonstrated that it can also be used for racemic 
compounds starting from solutions having a composition close the eutectic one (e.g. light grey 
point in Fig. 3b).[111, 113]  2) Further, as indicated in Fig. 3b by the black point, an initial step might 
be applied exploiting enrichment in the liquid phase. Hereby just a slight initial enantiomeric 
enrichment is sufficient to provide a liquid phase, which under certain conditions allows for 
subsequent selective crystallization of a pure enantiomer. Attractive process options arise if the 


























In summary, except for preferential crystallizations of conglomerates, crystallization-based 
racemate resolutions usually require a certain enantiomeric enrichment, which might be 
provided in an integrated process via partially selective synthesis or a prior alternative 
separation step. 
 
3.2 Illustration of selected melt and solution equilibria 
In the last years in our group more than 30 chiral substances originating from the fields of fine 
chemicals (chemical intermediates, amino acids) and pharmaceuticals have been characterized 
by their binary and/or ternary phase diagrams, considering also diastereomeric salts. In Table 1 
a selection of 14 chiral substances is compiled specifying the type of the crystalline racemate 
and the eutectic composition in the chiral system determined from the melt phase and ternary 
solubility phase diagrams. In some cases different solvents have been studied, e.g. for N-
methylephedrine as a conglomerate and mandelic acid as a racemic compound-forming 
system, solubilities in eight andeleven, respectively, different achiral and chiral solvents were 
measured. Table 1 further contains thermodynamic information not acquired in our lab for 
Tröger’s base discussed below as a model compound.[153-169] 
The systems studied show a wide variety of characteristics, such as polymorphy of the 
enantiomers or/and racemate, solvates, solid solutions and a variation of the eutectic 
composition as a function of temperature or solvent. Five chiral systems form conglomerates, 
nine racemic compounds. Just threonine and the pharmaceutical intermediate A turned out to 
belong to the simplest type of phase diagrams, i.e. being a conglomerate and showing no 
polymorphs, solvates or solid solutions in the range of conditions investigated. Hard to track 
cases were 3- and 2-chloromandelic acid (Tables 1 and 2), which are both racemic compound-
forming systems. In case of 3-chloromandelic acid for both the enantiomers and the racemic 
compound monotropic modifications exist.[163] For 2-chloromandelic acid (Table 2) a metastable 
conglomerate was found[170]. For the relatively simple compound malic acid an additional 
monotropic polymorph of the racemic compound as well as partial miscibility of the enantiomer 
and the racemic compound were observed. The rather rare occurrence of systems showing no 
additional solid phases or solid solutions corroborates the importance of solid phase analysis 
when measuring SLE data, an issue in many investigations not considered. 
Table 2 summarizes the different eutectic compositions determined in the melt phase diagrams 
for a selection of mandelic acid derivatives. All belong to the racemic compound-forming type of 
substances. The 2-substituted mandelic acid derivatives show eutectic compositions close to 
the racemic one. Increased xeu-values are obtained for 3- and 4-substituted derivatives with 
medium values for the 4-substituted compounds. The same holds true for the di-substituted 2-




Table 1: Chiral systems studied regarding their melt and solution phase equilibria. 
 
Chiral substance Type of phase 
diagram/ 
racemate 
xeu  binary 
melt system 







Threonine C - 0.5 (w, w/EtOH) - [153, 154] 
Asparagine C - 0.5 (w) C: hydrate [155] 
Methionine RC - 0.94-0.85 (1-60°C) (w) (variable xeu) [156] 









N-methylephedrine C 0.5 0.5 (8 solvents) polymorphy [e.g. 137, 158, 
159] 




RC  0.89 
(0.85 
metastable) 
0.9-0.84 (5-50°C) (w) 
0.9 (toluene) 
polymorphy of 





C 0.5 0.5 ss (<0.25, >0.75) [164] 
Malic acid RC  0.967 0.985 (w) polymorphy of RC, 
ss of RC (~0.7) 
[149] 
Tröger’s base RC 0.85 0.92-0.885 (25-50°C) 
(EtOH) 
(variable xeu) [165] 
Pharmaceutical intermediates and active pharmaceutical ingredients (API) 
Compound A C 0.5 0.5 (acetonitrile) - [153] 
Propranolol hydro-
chloride 
RC  0.55 0.55  (w, MeOH) 
 
polymorphy of RC, 
ss of enantiomer, 
(0.982) 
[147, 166] 
Bicalutamide RC 0.9 0.977-0.95 (0-60°C) 
(MeOH/w) 
(variable xeu) [167, 168] 
2, 6-
Pipecoloxylidide 
RC 0.67 0.7 (dibutylether) solvates, 
polymorphy of RC 
[169] 
[a] All amino acids decompose during or before melting, thus no melt phase diagram can be determined. 
C: conglomerate; RC: racemic compound; xeu: eutectic composition in the chiral system (just given for x≥0.5); EtOH: 
ethanol; MeOH: methanol; w: water; ss: solid solutions 
 
 
Table 2: Eutectic compositions, xeu, in the melt phase diagrams of different mandelic acid derivatives.[171] 
 
Substance xeu 
2-chloromandelic acid 0.57 
3-chloromandelic acid 0.89 
4-chloromandelic acid 0.83 
2-bromomandelic acid 0.54 
3-bromomandelic acid 0.87 
4-bromomandelic acid 0.76 
2-chloro, 4-fluoromandelic acid 0.56 
4-chloro, 2-fluoromandelic acid 0.73 
3-methylmandelic acid 0.63 
 
In the following, the application of different concepts of crystallization-based separation of 
enantiomers will be demonstrated describing results of selected case studies. 
 
3.3 Demonstration of various concepts of crystallization-based enantioseparation  
Below classical and innovative crystallization processes capable to separate enantiomers will 
be illustrated using four of the compounds listed in Table 1 characterized by different but typical 
thermodynamic properties and diverse kinetic crystallization behavior. The compounds 
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considered are threonine, mandelic acid, methionine and Tröger’s base. All results given below 
have been collected in our laboratory in the last decade. 
 
3.3.1 Conglomerates 
Among the four compounds considered, threonine is the only one that belongs to the group of 
conglomerates. Threonine, an essential amico acid, occurs in nature as the (2S, 3R)-form 
designated as L-threonine. Since it contains two chiral centres, four stereoisomers are possible, 
giving two pairs of enantiomers, L- and D-threonine (L-Thr, D-Thr) as well as L-allo-threonine and 
D-allo-threonine. The corresponding structures are shown in Fig. 4. 
             
Figure 4: L-(2S,3R)-(-)-threonine, D-(2R,3S)-(+)-threonine, L-(2S,3S)-(+)-allo-threonine, D-(2R,3R)-(-)-allo-threonine 
 
Separations will be demonstrated for the example of the L- and D-threonine pair. The ternary 
solubility phase diagram with water as solvent is presented in Fig. 5 providing four solubility 
isotherms between 10 and 40°C. As expected, symmetrical behavior around the racemic 
composition is obtained and the solubility isotherms exhibit the typical shape of a simple 
eutectic (conglomerate) system. Solubilities increase with temperature, as frequently observed. 
Further, solubility isotherms run almost parallel to the opposite triangle sides, i.e. the solubility of 
one enantiomer is not affected by the presence of the counter-enantiomer which indicates close 
to ideal solution behavior. 
In Fig. 6 is illustrated the principle of preferential crystallization for conglomerates. Starting from 
a racemic composition in the three-phase region of the phase diagram (black point in Fig. 6a), in 
presence of homochiral seeds (here the (-)-enantiomer), it is possible to crystallize just the 
seeded enantiomer for a certain period of time. The crystallization trajectory is indicated by an 
arrow. When finally reaching the metastable solubility line of the crystallizing enantiomer, the 
separation process has to be interrupted to avoid nucleation of the counter-enantiomer and 
thus, contamination of the target product. What makes the process attractive for industrial 
application is the fact, that it can be performed in a cyclic mode providing both enantiomers in a 
periodic manner (Fig. 6b). There, trajectories AB and CD represent the selective 
crystallization pathways of the (-)- and (+)-enantiomer initiated by addition of respective seeds. 
In between (BC, DA) the crystallized products are filtered off and new racemic feed is 
added. Online monitoring of the separation progress (measuring the solution composition by 
combination of polarimetric and density detection) has proven to facilitate a reliable separation 
process.[172, 173] Additional application of inline particle measurement techniques (such as 
Focussed Beam Reflectance Measurement (FBRM®) or videomicroscopy) allows for monitoring 
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the evolution of the solid phase with regard to particle size, particle size distribution, particle 
shape etc.[174-176] 
 
Figure 5: Ternary solubility phase diagram of L- and D-Thr in water. Since the solubilities of the threonine species in 
aqueous solution are comparatively small, only the upper half of the solubility phase diagram is shown 




Figure 6: Illustration of the principle of preferential crystallization in the ternary solubility phase diagram. Shown is 
a) a trajectory of preferentially crystallizing a single enantiomer and b) a cyclic process producing 
periodically both enantiomers in an isothermal process at a crystallization temperature, Tcryst. Black points 
indicate the starting points and gray dashed lines the metastable solubility lines of the enantiomers and, 
thus, the crystallization limit for successful preferential crystallization. 
 
Results of this classically isothermal process are presented e.g. in [110]. To enhance the process 
performance with respect to robustness, productivity and product purity, different more 
sophisticated process modes have been suggested, namely polythermal crystallization 
procedures, auto-seeding strategies and alternative crystallizer concepts. Exemplarily, the 
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potential of a promising auto-seeded polythermal mode of preferential crystallization[118] shall be 
briefly illustrated using the threonine case study. The process comprises a cooling 
crystallization that allows for enhanced yields and improved product purities and, further, a 
particular auto-seeding supplying well-conditioned seeds for reliable separation. Fig. 7 
illustrates a typical temperature profile applied for a complete separation cycle. In Fig. 8 the 
resulting profiles of the optical rotation angle as a function of time are represented for five 
consecutive separation cycles of DL-threonine using aqueous solutions. 
 
Figure 7: Schematic temperature profile applied in cyclic auto-seeded polythermal preferential crystallization. 
 (Tsat, Tsusp and Tend, saturation, suspension and end temperature of the cooling crystallization process; t, 
time; points A, B, C, D characterize the production periods of the separation cycle providing periodically L-
Thr and D-Thr, compare with Fig. 8).[based on 175] 
 
 
Figure 8: Profiles of the optical rotation angle, α, for five consecutive separation cycles in auto-seeded polythermal 
preferential crystallization of threonine. Just the sole crystallization periods AB and CD are 
shown.Crystallization conditions: 1000 g solution; 20 Kh-1 cooling rate; Tsat, Tsusp, Tend: 53°C, 39°C, 
4°C.[based on 175] 
 
Unlike the isothermal process described before, each new half cycle now starts after addition of 
racemic feed with adjusting the temperature somewhat below the saturation temperature of the 
mixture (suspension temperature, Tsusp, Fig. 7) in order to facilitate selective dissolution of just 
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and addition of new racemic feed to the mother liquor), the L-Thr crystals in the racemate are 
completely dissolved. After subjecting the remaining D-Thr crystals to a conditioning phase (e.g. 
C*C, Fig. 7), they exhibit well-formed faces and a smooth, healed surface and serve as seed 
crystals for the subsequent cooling crystallization providing D-Thr as product (CD, Figs. 7, 8). 
In the runs shown, the purity of L- and D-Thr gained was in the average 99.1%[175]. With a 
connected mean yield of 4.1% per half cycle[175], the separation performed appears to be 
economically attractive according to estimations made by Collet.[94] 
As for many processes that are based on recycling, accumulation of impurities is also an issue 
of importance for cyclic preferential crystallization processes. The influence of L- and D-allo-
threonine accumulating as impurities with increasing cycle numbers in preferential crystallization 
of D- and L-threonine was discussed and evaluated in [174]. There, also the application of a 
modified auto-seeding strategy is presented. It is shown that, within certain limits, in 
dependence of the seed characteristics, the properties of the produced crystals (shape, size) 
and the productivity of the separation can be adjusted.[112] 
A further opportunity to improve the performance of preferential crystallization is to apply tailor-
made additives that selectively inhibit the crystallization of one of the enantiomers and, thus, 
allow for increased yields of the desired enantiomer.[106, 107]For resolution of racemic threonine, 
L-glutamic acid is known to selectively suppress nucleation and crystallization of L-Thr. 
Experiments showed that in presence of L-glutamic acid both the process robustness and the 
yield for crystallization of D-Thr as target product is enhanced.[112] Further, in literature the 
application of chiral polymers based on poly (N-acryl) amino acids as chiral additives has been 
reported to induce enantioselective crystallization of amino acids in solution. For example, for 
DL-Thr in presence of 1 mg/ml of poly-L-leucine high chiral discrimination at the early 
crystallization stages has been observed.[177] 
Different innovative concepts of alternative crystallizer configurations are presented in [110]. One 
concept considers simultaneous preferential crystallization in two crystallizers coupled via the 
liquid phase. The enhanced performance provided by this concept is illustrated in Fig. 9, where 
measured concentration profiles of the threonine enantiomers in the coupled crystallizer mode 
are compared to results for classical preferential crystallization performed in a simple batch 
mode. 
Due to the exchange of mother liquors, in both crystallizers the concentration of the undesired 
enantiomer is decreased and the concentration of the crystallizing target enantiomer (i.e. also 
the driving force for growth) is increased. In both vessels the mother liquor composition is 
always close to the racemic one (i.e. almost identical concentrations of L- and D-Thr, Fig. 9), 
which prevents the corresponding counter-enantiomer from nucleation. As a result, improved 
process robustness and increased productivity could be achieved. More details and an option 




Figure 9: Concentration profiles of the enantiomers in the liquid phase for simple batch and coupled crystallization 
mode.[116] Full symbols and italic letters represent the simple batch mode, open symbols and regular 
letters represent the mode using two crystallizers coupled via their liquid phases. 
 
3.3.2 Racemic compound-forming systems 
a) Mandelic acid 
Mandelic acid (MA) and its derivatives have several pharmaceutical applications, such as the 
treatment of urinary tract infections due to their bacteriostatic properties[179] and as a 
pharmaceutical constituent due to analgesic, antirheumatic and spasmolytic effects.[180] 
Furthermore, pure (R)-mandelic acid is used as a precursor for synthesis of cephalosporin and 
penicillin.[181] Both enantiomers, (S)- and (R)-mandelic acid (Fig. 10), belong to the most 
frequently applied acidic resolving agents utilized in classical resolution.[39] E.g. mandelic acid is 
used at an intermediate step of Duloxetine synthesis ((S)-MA, 2004) and in manufacturing 
Sertraline ((R-)-MA, 1990).[39] The latter one is among the top ten drugs and thus, one of the 
nine chiral blockbusters.[182] The commercial process to Sertraline was recently modified, 
starting the synthesis with a continuous chromatographic resolution of the racemic starting 
material.[39, 183] Nevertheless, advanced variants of diastereomeric resolution with (R)-MA 
implementing racemization of the undesired enantiomer providing both good economics and 
high-quality products are under development.[85] 
                 
Figure 10: (S)-(+)-mandelic acid, (R)-(-)-mandelic acid, (RS)-(±)-mandelic acid. 
 
Here, we use mandelic acid as an example of a racemic compound-forming system to be 





























































ternary solubility phase diagrams of the mandelic acid enantiomers are shown in a) water and 
b) (2R, 3R)-diethyl tartrate (DET) as an example of a chiral solvent. Our results confirmed the 
already known character of mandelic acid as racemic compound-forming.[82] The eutectic 
composition measured for the binary melt system at a weight fraction (w) of 0.7 and 
0.3,respectively,[160] remains unchanged in presence of both solvents involved. Even when 
applying the chiral solvent DET (and also other optically active solvents, e.g. lactates[137]), no 
recognizable asymmetry is introduced in the MA phase diagram, that could be applied for 
separation purposes. In both solvents shown, the solubility of the mandelic acid species 
increases with temperature and is higher for the racemic compound than for the enantiomers. 
 
Figure 11: Ternary solubility phase diagrams of the mandelic acid enantiomers in a) water[153] and b) (2R, 3R)-diethyl 
tartrate.[162] Isotherm lines are guides to the eyes. 
 
Though no quantifiable impact on solution thermodynamics in terms of different solubilities of 
the mandelic acid enantiomers in the chiral solvents was observed,[135] in case of kinetics 
pronounced selective inhibition effects were obtained in metastable zone width (MZW) studies 
in (2R, 3R)-diethyl tartrate and also in (S)-ethyl lactate.[136] For example, the MZW with respect 
to primary nucleation was found in (2R, 3R)-diethyl tartrate to be smaller for (R)-mandelic acid 
than for (S)- and racemic mandelic acid, facilitating preferential nucleation of the (R)-enantiomer 
and, thus, its selective crystallization. In Fig. 12 a typical result of a preferential nucleation 
experiment for racemic mandelic acid in (2R, 3R)-diethyl tartrate is presented. As expected from 
MZW data, with occurrence of nucleation, a decrease in solution density and increase in optical 
rotation of the solution was observed indicating crystallization of (R)-(-)-mandelic acid. Hence, 
enantioselective crystallization was feasible directly from the racemic solution without “investing” 
in a prior enantiomeric enrichment step. 
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Recently, application of certain mandelic acid esters as chiral “task-specific”solvents provided 
evidence of chiral recognition in the solution phase, indicated by clear solubility differences of 
the mandelic acid enantiomers.[138] 
 
Figure 12: Profiles of the optical rotation of the mother liquor and the solution density during a preferential nucleation 
experiment starting with racemic mandelic acid in (2R, 3R)-diethyl tartrate at Tsat=55°C. The initial optical 
rotation of about 10.85° characterizes the optical rotation of the starting solution influenced by the chiral 
solvent.[136] 
 
As shown on the example of threonine, preferential crystallization can be used to resolve 
racemic mixtures of conglomerates. Here, it should be demonstrated that this method is also 
applicable to racemic compound-forming systems when starting from solutions being enriched 
with the target enantiomer.[110, 111, 113, 114, 117, 166, 184] In principal, since both the enantiomer and 
the racemic compound can be crystallized separately, it should be feasible to preferentially 
crystallize them in the three-phase region of the ternary solubility phase diagram in a periodic 
manner similar as the two enantiomers for conglomerates.  
Characteristic trajectories of a cyclic auto-seeded polythermal preferential crystallization for a 
racemic compound-forming system are illustrated in Fig. 13. In Fig. 14 the applicability of this 
technique for enantioseparation in the mandelic acid system is demonstrated. The measured 
trajectories principally look similar to the threonine case (Fig. 8), but differ in the fact, that the 
process is not any more symmetrical around the eutectic line. The maximum difference in 
enantiomeric excess (∆ee) attainable by preferential crystallization can be unequal for the 
racemic compound and the enantiomer (e.g. ∆ee~6% vs. 4%, Fig. 14), since it depends on the 
particular eutectic composition of the chiral system. For mandelic acid, racemate and 
enantiomer can be gained in a ratio of 3:2 according to the eutectic at an ee of 40% (eeeut, Fig. 
14). In an integrated process scheme, where first a certain enantiomeric enrichment is achieved 
that is used subsequently for preferential crystallization, the racemic compound can be recycled 
as a by-product of the cyclic process via the enrichment step. Moreover, as demonstrated 




































offers also for mandelic acid further improvement of process performance in terms of yield and 
reliability.[115, 117] Just recently, the application of hydroquinine-4-methyl-2-quinolylether as a 
chiral additive in preferential crystallization of mandelic acid was described. [185] Due to its 
particular effect on nucleation kinetics this additive also allows for significant enhancements in 
yield. 
 
Figure 13: Illustration of a cyclic auto-seeded polythermal preferential crystallization process providing periodically 
the racemic compound and the (+)-enantiomer of a racemic compound-forming system.[113] The notation 
refers to the temperature profile given in Fig. 7. 
 
 
Figure 14: Profiles of enantiomeric excess for four consecutive separation cycles in auto-seeded polythermal 
preferential crystallization of mandelic acid.[113] Just the sole cooling crystallization periods AB and 
CD are shown. Selected crystallization conditions: 300 g solution; 15 Kh-1 cooling rate. 
 
b) Methionine and Tröger’s base 
The amino acid methionine (Fig. 15) is an essential sulphur containing amino acid that (as all 
proteinogenic amino acids) is found in nature as the L-enantiomer. It is of particular relevance 
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methionine, since it can be transformed into the desired L-enantiomer by the animal organisms. 
Pharmaceutical application is given as liver protection agent and in infusion solutions.[186] 
Methionine was used in our study as a model system to discuss separation strategies 
applicable for substances with similar phase diagram characteristics. 
                      
Figure 15: D-(R)-(+)-methionine, L-(S)-(-)-Methionine, DL-(RS)-(±)-methionine 
 
Fig. 16 shows the ternary solubility phase diagram of the methionine enantiomers in water, 
which is clearly of racemic compound-forming type. The solubilities are found to be 
comparatively low, in particular for the racemic compound. The eutectic composition in the 
chiral system is close to the pure enantiomer side and varies with temperature. Actually, it 
decreases from xeu=0.94 at 1°C to 0.85 at 60°C. Such an alteration of the eutectic composition 
has been reported for several compounds such as serine[157], 3-chloromandelic acid[163], the API 
Bicalutamide,[167] a further pharmaceutically relevant substance investigated by Wang and 
coworkers[187] and Tröger’s base.[165] 
 
Figure 16: Ternary solubility phase diagram of the methionine (Met) enantiomers in water. Just the upper 10% of the 
phase diagram are shown due to the low solubilities in the system. Isotherm lines are guides to the 
eyes.[156] 
 
The phase diagrams of methionine and Tröger’s base[165] exhibit very similar characteristics. 
The solubilities in both systems (methionine/water, Tröger’s base/ethanol) are comparatively 
low and both form an intermediate compound at racemic composition, which at same 
temperature has significantly lower solubility than the enantiomers. As result, the eutectic 
composition left and right from the racemic compound occur close to the enantiomer sides in 
the phase diagram. Further, as a function of temperature, the eutectic lines show convex 
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profiles, i.e. a high eutectic composition at low temperature shifts to lower values at elevated 
temperatures. For Tröger’s base this shift in the eutectic composition is with w=0.92 at 25°C to 
0.885 at 50°C[165] close to the methionine data.  
Tröger’s base ((±)-2,8-dimethyl-6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine) is a chiral 
heterocyclic amine whose chirality is solely due to the presence of two stereogenic nitrogen 
atoms (Fig. 17). It is frequently used as a model system to study enantioseparation, e.g. in 
investigations of chiral chromatography (see chapter 4.4). Further, its derivatives are applied as 
substrates in organic and biochemistry.[188, 189] Worlitschek et al.[165] measured the binary melt 
and ternary solubility phase diagrams in ethanol and described the SLE using the classical 
Schröder-van Laar and Prigogine-Defay equations[82] and the NRTL model to account for non-
ideality in solution. Crystallization-based resolution of racemic Tröger’s base has been achieved 
via diastereomer-mediated resolution with a strongly acidic resolving agent. The resolution was 
found to be attended by a crystallization-induced asymmetric transformation of the salt 
containing the (+)-enantiomer of Tröger’s base providing high yield.[190] A hybrid 
chromatography-crystallization process for resolution of Tröger’s base has been studied by 
Amanullah and Mazzotti.[191] 
 
Figure 17: Structures of (-)-Tröger’s base, (+)-Tröger’s base and (±)-Tröger’s base. 
 
Exploiting the shift of the eutectic composition in the chiral system with temperature, an 
alternative two-step process for enantioseparation can be suggested. It is illustrated for 
methionine in Fig. 18.[151, 152] Starting at a low temperature, T1, from a (just slightly) 
enantiomerically enriched solution (point 1), evaporation of solvent provides a solution of a 
composition inside the three-phase region of the phase diagram (point 2). Equilibration results 
in a solid phase of composition (3) depleted in the target enantiomer and a saturated solution of 
eutectic composition, xeu,1,(4) enriched in the target enantiomer. After filtering-off the crystalline 
phase, further removal of solvent shifts the solution composition at a higher temperature, T2, 
within the two-phase existence region of the target enantiomer (point 5) supplying it enantiopure 
(6). Maximum yield is provided when the solution composition meets the phase boundary 
between the two- and adjacent three-phase region (point 5’).  
The process suggested can be performed in a cyclic manner as illustrated in the flow scheme in 
Fig. 19. The crystalline phase of the 1st step, the solvent and the mother liquor of the 2nd step 
can be fully or partially recycled attaining an efficient utilization of the process educts. The 
potential of this process was successfully demonstrated.[151] 
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Figure 18: Two-step process for enantioseparation in the methionine system exploiting the shift in the eutectic 
composition with temperature; a) step 1: enrichment in the liquid phase at a low temperature, T1; b) step 
2: evaporation of solvent and selective crystallization of L-Met at a higher temperature, T2.[151] 
 
 
Figure 19: Flow scheme of the two-step separation process for methionine considering partial or full recycling of the 
solid separated in the 1st step, the solvent and the mother liquor of the 2nd step (target enantiomer: L-
Met).[151] Characteristic numbers correspond to points in Fig. 18. 
 
The next chapter introduces the principle and process concepts of preparative chromatography 




















4. Chromatographic separation of enantiomers 
The development of enantioselective chromatographic methods capable to resolve racemates is 
described in several excellent books and reviews.[31, 36, 38, 192-202] 
As in the area of crystallization, also in chromatography extensive efforts are devoted to apply 
suitable chiral derivatizing reagents in order to generate diastereomers which can be separated 
using classical chromatographic techniques used for the separation of achiral molecules. Since 
this so-called indirect method is characterized by a couple of drawbacks, as the different rates 
of transforming the two enantiomers or the danger of racemization[200],for preparative purposes 
the direct method which circumvents laborious derivatizations is seen as the more successful 
one. 
Column chromatography using solid stationary phases is one of the most powerful 
enantioselective separation techniques. This is mainly due to the wide spectrum of possibilities 
offered by adjusting both the fluid mobile phase and the stationary phase to the requirements of 
the separation problem. 
Depending on the properties of the feed mixture, gases, liquids and supercritical fluids are 
applied as the mobile phase. Pioneers in chiral GC are Gil-Av[203], Schurig[204], König [205] and 
Franck et al.[206]. However, for preparative applications this technique has still almost no 
importance. For nonvolatile and/or thermally labil compounds the wide spectrum of liquid 
chromatographic techniques provides the platform for numerous chiral HPLC methods. The 
current state of the art was recently reviewed in [207]. A renewed interest in supercritical fluid 
chromatography (SFC) led in the last years to the development of successful enantioselective 
separations using supercritical CO2 as the main constituent of the mobile phase.[208, 209] 
In conventional High Performance Liquid Chromatography (HPLC) it can be often chosen 
between several separation methods, i.e. combinations of mobile and stationary phases.[207, 210] 
This advanced state has not yet achieved regarding the task of separating enantiomers. To 
solve such complicated separation problems suitable chromatographic methods are still often 
developed empirically. However, considerable progress has been achieved in the last years in 
understanding important principles of chiral recognition.[211]Supported by the development of 
specific and highly productive process concepts and the provision of the corresponding design 
tools, nowadays chromatographic techniques allow separating virtually any mixture of 
enantiomers. 
Regarding the selection, which of the two phases should be chiral to efficiently perform the 
chromatographic separation, there have been several efforts made to develop methods using 
chiral mobile phases or adding specific chiral additives to achiral mobile phases. An example is 
the separation of acid enantiomers by forming ion pairs with chiral bases such as quinines.[212] 
Ligand exchange methods have been reviewed in [213]. However, the use of chiral mobile 
phases appears to be not well suited for preparative LC. Often the chiral agents can not be 
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easily recovered and recycled. In addition, the capacities of the chromatographic systems are 
typically much lower compared to systems based on chiral stationary phases (CSP). 
The application of CSP is generally the most straightforward and convenient means for 
chromatographic enantioseparation and typically the method of choice, in particular for 
preparative applications.[200] It is based on creating and exploiting selective interactions at a 
solid-liquid interface. Hereby, the solid support has a large influence on the mechanism of 
complexation, which causes the selectivity to be different from the selectivity in a liquid-liquid 
environment. Currently, there is a large and permanently growing arsenal of selective CSP 
commercially available, which allows separating a broad spectrum of racemates. Important CSP 
will be introduced in section 4.1. 
Chromatographic techniques are widely used in industry to purify smaller amounts of target 
enantiomers in early development stages. However, these techniques become increasingly a 
tool for production of larger quantities.[38, 199] Since large scale (industrial) chromatographic 
processes are expensive, they require a careful design and optimization. In the last years the 
theoretical understanding of preparative chromatography operated under overloaded conditions 
has improved significantly.[214-216] Theoretical analysis of band propagation processes occuring 
in packed columns revealed that in the design of preparative chromatographic processes the 
nonlinearities in the underlying distribution equilibria have to be taken into account.[216] 
Compared to conventional analytical chromatography, isocratic batch elution concepts are 
frequently not adequate and various alternative concepts have been developed in order to 
increase productivities and yields and to decrease solvent consumptions, e.g. several recycling 
techniques.[215, 216]A breakthrough in increasing the productivity was achieved by applying for 
chromatographic enantioseparations the multi-column simulated moving bed (SMB) 
technology[217]developed in the petrochemistry and based on continuous countercurrent 
principles.[218] The process concept will be explained in section 4.2. 
 
4.1 Chiral stationary phases 
The production, characterization and application of CSPs and their corresponding 
enantioselective columns has been described in excellent book chapters and reviews.[37, 200, 
219, 220] 
The chiral selectors of CSP are preferentially covalently linked or alternatively strongly 
physically adsorbed (e.g. by coating with a polymeric selector) to a chromatographic support 
(usually porous silica particles). These CSP are applied with achiral mobile phases. During 
migration of the sample through the column diastereomeric complexes are formed within the 
stationary phases retaining the individual enantiomers in a specific manner. 
The principle of chiral recognition has been rationalized earlier frequently using the classical 
“three point interaction model” suggested by Dalglish.[221] The numerous more detailed 
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mechanisms suggested were reviewed on a regular basis.[211, 222] Currently there are intensive 
attempts to use density functional theory and molecular dynamic simulations to understand and 
predict the distribution of the enantiomers at the interface between mobile phases and 
CSP.[e.g. 8, 223, 224] 
An essential aspect for a successful preparative separation is to find a combination of CSP with 
a mobile phase that allows for high solubility of the enantiomers and for “reasonable” retention 
times in the columns. Hereby, both too long and too short retentions are not desirable. Despite 
of the considerable improvement in understanding separation mechanisms, due to the large 
number of degrees of freedom the standard technique to identify for a specific 
enantioseparation problem a suitable CSP is still based on screening a smaller are larger set of 
available stationary phases and various mobile phases. Regarding the latter typically solvent 
mixtures are applied in order to adjust retention times. This screening is frequently supported by 
the manufacturers of the CSP. 
A broad variety of chiral selectors, of both natural and synthetic origin, have been applied in 
CSP. More than hundred CSPs are offered nowadays commercially, among which probably 
around 20 are most frequently used.  
There are various classifications for CSP.[200, 220, 225] We follow in the short overview given below 
the grouping of the most important selectors for CSP applied in[200]. 
 
Macromolecular selectors of semi-synthetic origin (polysaccharide-based CSPs) 
Polysaccharide selectors have a long tradition. Hesse and Hagel introduced in 1973 
microcrystalline cellulose triacetate (Fig. 20) as a polymeric selector material (without 
support).[226] By coating different cellulose derivatives (e.g. amylose tris(3,5-
dimethylphenylcarbamate, Fig. 20) to marcoporous silica beads Okamoto and coworkers made 
highly enantioselective materials with higher pressure stability and chromatographic efficiency 
which were successfully commercialized by Daicel Chemical Industries.[227] 
 
Figure 20: Polymer backbone of polysaccharide based CSPs, left: Cellulose triacetate (CTA), right: ChiralpakAD. 
 
Currently there are phases available, which can be used for a wide spectrum of solvents due to 
improved selector immobilization. This allows choosing mobile phases offering a maximum in 
solubility which, together with the typically high enantioselectivities, makes this group of CSP 
very attractive for preparative applications.[228, 229] 
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Macromolecular selectors of synthetic origin (synthetic polymer CSPs) 
Several chiral synthetic polymers have been developed and are applied as potential chiral 
selectors to mimic the enantioselectivity provided by the semi-synthetic polysaccharides. A 
review regarding polyacrylamide/silica composites was given by Kinkel.[230] Probably due to 
much less ordered structures of the polymer chains these materials often do not achieve the 
same enantiorecognition as the polysaccharide phases. 
 
Macromolecular selectors of natural origin (protein phases) 
After the pioneering work of Allenmark and coworkers[231] and others, who investigated the 
steroeselective binding of chiral components to proteins, nowadays a variety of protein-based 
CSPs is well documented[232] and commercially available.[200] A drawback of protein phases is 
their limited sample loadability, making them less attractive for preparative chiral 
chromatography. 
 
Macrocyclic oligomeric or intermediate-sized selectors (cyclodextrins, macrocyclic 
antibiotics, chiral crown ethers) 
This type of selectors provides the basis for a large and important group of CSPs. 
Cyclodextrin bonded CSP are based on α-, β, or γ-cyclodextrins, i.e. on macrocyclic structures 
that are assembled from 6, 7 or 8 glucose units, respectively.[233, 234] The cyclodextrins are 
usually bonded to silica gel, either via ether linkage or via carbamate linkage. 
Inspired from the stereoselective inclusion capabilities of the macrocyclic cyclodextrins, 
Armstrong and coworkers developed a new very successful class of CSP: the macrocyclic 
antibiotic CSPs. The first type of this class was vancomycin-modified silica.[235] In the meantime 
the company ASTEC (now Sigma Aldrich, USA) has commercialized several other CSP based 
on glycpeptide antibiotics[235]. The structure of Teicoplanin, which is the selector of the 
commercially available CSP Chirobiotic T, is given in Fig. 21 as an example. High loadibilities 
were achieved for Teicoplanin Aglycone (CHIROBIOTIC TAG)[235d]. 
Other interesting representatives of this group of CSP are chiral crown-ether phases developed 
initially by Cram and coworkers.[236] 
 
Synthetic neutral entitities of low molecular weight (Donor-acceptor phases/Pirkle 
phases) 
The first commercialized CSP with entirely synthetic selectors were developed by Pirkle and 
coworkers.[200] A DNB-phenylglycine derivative immobilized ionicly onto silica was used as the 
selector. Later a larger collection of donor-acceptor type of CSPs was developed,[237] which 
exploit frequently π-π-stacking interactions between electron-rich and electron deficient aromatic 
systems as the primary attractions. Particularly successful is currently the so-called Whelk-O1 
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phase that has pre-organized clefts for solute insertion and allows for simultaneous face-to-face 
and face-to-edge π-π-interactions. An interesting advantage of these CSP is the fact that, due to 
the availability of the selectors in both enantiomeric forms, the elution order can be selected.[238] 
 
 
Figure 21: Structure of the glycopeptide antibiotic Teicoplanin, which is the selector in theCSP Chirobiotic T (with 4 
inclusion cavities A, B, C and D). 
 
Synthetic ionic entities of low molecular weight possessing ion-exchange properties 
Several ion-exchangers have been developed for the separation of ionisable chiral compounds: 
e.g. chiral anion-exchangers based on cinchona alkaloid derivatives to resolve chiral acids[211, 
239] or chiral cation-exchangers based on chiral amino sulfonic acids and caboxyxlic acids for the 
separation of chiral bases.[240] Best described are the anion-exchangers using as the cinchona 
alkaloids quinine and quinidine as backbone of the selectors. The corresponding columns 
appear to be very promising in particular due to their remarkable sample loadability.[200] 
 
Chelating selectors for chiral ligand-exchange chromatography 
The first chiral ligand exchange CSPs were developed in the late 1960s. The method is based 
on the reversible coordination of immobilized selectors and analytes within the metal-ion 
coordination sphere that forms a mixed ternary metal-ion/selector/analyte complex[200]. 
Davankov immobilized e.g. praline onto a polystyrene support and used this enantioselective 
matrix in combination with Cu(II)-ion containing mobile phases for the enantiomer separation of 
amino acids[241]. An overview about the method is available in[242]. 
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In the references mentioned above a broad spectrum of separation problems and examples is 
described. The important problem of the loadabilities and saturation capacities of the CSP is 
addressed in [219, 220].The identification of the most suitable chromatographic system so solve a 
specific separation problem using systematic column screening was described recently[243]as 
well as attempts of miniaturization in order to allow for high throughput methods.[244] 
 
The intensive research activities in the area of developing improved CSP will for sure contribute 
in the future to the provision of further improved solid chiral stationary phases. However, 
besides finding the right CSP for tackling an enantioseparation problem, it is still an important 
task to properly design a separation process for preparative purposes and to select the most 
suitable operating mode. 
 
4.2 Preparative chromatography 
In analytical applications of chromatographic separation relative small sample sizes are injected 
into a single column. This causes more or less Gaussian shapes of the eluting peaks. Together 
with the efficiencies of the columns (i.e. the plate numbers), the retention times and the 
selectivities between the components to be separated are the main parameters that must be 
adjusted and optimized. 
The objectives are different in preparative chromatography. Here the columns have to be 
heavily overloaded to achieve high productivities. This is done by injecting larger 
concentrations, often close to the solubility limits, and/or larger sample volumes. As a 
consequence nonlinear regions of the distribution equilibria control the separation and lead 
typically to highly asymmetric and distorted peaks shapes. Besides the selectivities, now the 
loadabilities of the stationary phases become very important. To increase productivities and 
recoveries and to reduce the solvent consumptions several alternatives to batch 
chromatography have been developed and are used in industry. Examples are given for 
example in [245, 246].One class of processes improving conventional batch chromatography 
exploits the principle of recycling not sufficiently resolved fractions, as e.g. the so-called steady-
state recycling.[247] The most important chromatographic techniques used for enantioseparation 
are reviewed in [38, 199, 248]. Useful hints and rules of thumb to develop a preparative 
chromatographic enantioseparation are given in [249]. 
Due to the fact that a quantitative understanding and design of preparative chromatography 
requires incorporating the nonlinear adsorption isotherms, the mathematical framework required 
for simulating the development of concentration profiles in the columns is more sophisticated 
than in analytical chromatography. However, nowadays sufficiently accurate model equations 
and the tools required to solve them are available.[214, 215] Thus, important features of nonlinear 
overloaded chromatography, as e.g. displacement and tag along effects and the mentioned 
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peak distortions, are well understood. Due to the lack of sufficiently accurate prediction 
methods, an important problem is still the fact that the adsorption equilibrium isotherms required 
must be determined experimentally. A broad spectrum of methods has been developed to 
perform this task.[250]Provided the thermodynamic functions and the column efficiencies are 
known, various types of operating modes can be well predicted and optimized. The theoretical 
framework available can be used to scale-up laboratory results to industrial scale columns.[251] A 
powerful modeling approach capable to simulate and design steady-state recycling 
chromatography was developed recently.[252] 
Due to the availability of both high capacity and selectivity CSP’s and mathematical tools 
allowing the design of various modes of operation, the separation of racemic mixtures using 
preparative liquid chromatography is currently in many cases the most rapid route to produce 
smaller quantities of pure enantiomers. In the last years a specific process applying several 
connected columns improved the potential of chromatographic enantioseparation and led to 
several large scale applications. This process will be introduced in the next section. 
 
4.3 Simulated moving bed chromatography 
The basic concept of simulated moving bed (SMB) chromatography was patented already in 
1961.[218] It was initially applied in the petroleum and sugar industries to separate e.g. the xylene 
isomers and fructose from glucose.[253, 254] 
In order to explain the SMB process it is expedient to explain at first a hypothetical true moving 
bed (TMB) process. As illustrated schematically in Fig. 22, the process is based on a 
countercurrent of the two phases involved, namely the fluid mobile phase and the solid phase 
(in this case not stationary). The TMB process is characterized by two streams entering the unit, 
i.e. the feed stream containing the mixture to be separated and the desorbent or eluent stream, 
and by two product outlet streams. The inlets and outlets divide the unit into four zones I, II, III 
and IV. The process acts as a binary fractionator and can separate mixtures consisting of two 
components A and B, e.g. two enantiomers. Under successful conditions one of the outgoing 
streams is enriched in the less adsorbable component A (the raffinate stream) and one is 
enriched in the more adsorbable component B (the extract stream). Each of the four zones has 
to fulfill distinct tasks. The separation of the two feed components should happen in the two 
central zones II and III. Here the net flowrates need to be set in such a way that component A is 
carried in the direction of the raffinate outlet and component B in the direction of the extract 
outlet. The desorbent is fed to zone I in order to desorb component B and thus to regenerate 
the solid phase. Component A is adsorbed on the solid phase in zone IV in order to regenerate 
the eluent. The process reaches a steady-state in which the positions of the internal 
concentration profiles do not change. Provided the flowrates have been adjusted correctly, a 
complete separation of the feed mixture can be achieved as illustrated in Fig. 22. 
 37 
The drawback of the TMB process described is the fact that a continuous transport of fragile 
solid particles without unwanted backmixing is hardly possible. This led to the suggestion of the 
simulated moving bed process (Fig. 23). Hereby the counter-current movements of liquid and 
solid phases are simulated by periodically shifting the positions of either the inlet and outlet 
ports or the columns. The residence time of a column in a zone is called the cycle or switching 
time, which is related to the solid-phase volumetric flow-rate of the corresponding TMB process. 
Thus, the SMB process mimics the TMB process mainting its attractive features. Due to the 
discrete switching events, the SMB process does not reach a steady state, which would be 
characterized e.g. by constant composition of the outlet streams. Instead, it reaches a “cyclic 
steady state”, which is characterized by a periodic repetition of concentration patterns in the 
zones and at the outlet ports. 
The recognition and acceptance of the SMB process in the pharmaceutical industry was 
retarded due to the difficulty of the separation problems, the higher product purity requirements 
and a lack of reliable design concepts. After the first successful enantioseparation using the 
SMB process in 1992[217], many more applications of this highly productive technique have been 
reported[e.g. 255-257]. Several comprehensive reviews describe the success story.[258-263] Typical 
productivities achievable with the technology are in the range of 1-10 kgEnantiomerkgCSP-1 day-1. 
The breakthrough of SMB chromatography as a powerful tool for enantioseparation is strongly 
related to the development of easy to apply design rules[264-266] together with the improved 
provision of the hardware required. 
 
 
Figure 22: Principle of true moving bed (TMB) chromatography and typical internal concentration profiles for a 




Figure 23: Principle of simulated moving bed (SMB) chromatography and typical internal concentration profiles at the 
end of a shift period for a successful binary separation. 
 
Besides the conventional 4-zone closed-loop SMB-process explained above, several improved 
modifications have been developed in the last years,[e.g. 267-270]considering also the application of 
supercritical fluids as the mobile phase.[271, 272] The availability of these variants broadened the 
spectrum of application[273] and led already to first successful continuous chromatographic 
purifications of biomolecules.[274] 
 
4.4 Illustration of preparative chromatographic enantioseparations 
In this section various features of enantioselective preparative chromatographic separation will 
be illustrated for the chiral molecules considered already in the section above describing options 
for enantioselective crystallization. 
The large arsenal of available chiral stationary phases (section 4.1) provides in most cases 
several possibilities to perform a chromatographic enantioseparation. Unfortunately, there is still 
no reliable theoretical framework available in order to identify quickly the best combination of 
chiral stationary and mobile phases for a given separation problem. Consequently this selection 
is typically based on screening studies injecting analytical (small) sample sizes on small lab 
scale columns filled with potential CSP candidates. Hereby sufficient solubility in the scanned 
solvents or solvent mixtures should be available. As an outcome of this empirical search, 
selectivities between the two enantiomers valid for diluted conditions can be evaluated based 
on the ratios of rentention times. Typically, in a second empirical stage more systematic work is 
carried out for the most promising chromatographic system(s). Hereby the adsorption isotherms, 
as the most essential information required for predicting chromatograms, have to be determined 
 39 
in a wider concentration range. These thermodynamic functions quantify the column capacities, 
allow optimizing operating conditions and discriminating between rivaling operating regimes 
and, thus, form finally the essential basis for the quantitative design of the chosen 
chromatographic separation process. 
 
a) Threonine 
An example for a successful chromatographic separation of a racemic mixture under analytical 
conditions is given in Fig. 24 for the amino acid DL-threonine. AChirobiotic T stationary phase 
(see Fig. 24) was used with a 60:40 ethanol-water mixture as the mobile phase. There is 
obviously a considerable selectivity that can be exploited for preparative purposes injecting 
periodically larger samples of DL-threonine. However, the development and application of a 
large scale chromatographic method appears to be not useful for the separation of these 
threonine enantiomers, because this amino acid belongs to the relative small group of 
conglomerates for which the preferential crystallization (Chapter 3) could be applied most 
efficiently offering a process far more attractive than the more sophisticated chromatographic 




Figure 24: Chromatographic separation of DL-threonine. Chiral stationary phase: Chirobiotic T (5 µm, L=250, d=4.6 
mm, ASTEC (Sigma Aldrich, USA), mobile phase: ethanol/water (60/40, v/v). Injection volume: 5 µl, 
injection concentration: 1% of DL-threonine in water, flowrate 0.5 ml min-1, T=24 °C, detection: UV at 200 
nm.[173] 
 
b) Mandelic acid 
Fig. 25 shows two chromatographic separations of a racemic mixture of the enantiomers of 
mandelic acid dissolved in water. Two types of chiral stationary phases were used in 
conventional HPLC columns (CSP I: the macrocyclic glycopeptide Chirobiotic T, using 
triethylammoniumacetate/methanol as the mobile phase, CSP II: a cyclodextrin based CSP 























regarding the conditions for the separation are given in the figure caption. Obviously, CSP I 
provides the higher selectivity for this separation.  
 
Figure 25: Chromatographic separations of racemic mandelic acid using two different chiral stationary phases. First 
peaks: (S)-(+)-mandelic acid, second peaks:(R)-(-)-mandelic acid. Injection volume: 1 µl, injection 
concentration: 1% of (RS)-(±)--mandelic acid in water, flowrate 0.5 ml min-1, temperature: 20 °C, 
detection: UV at 254 nm. CSP I:Chirobiotic T (ASTEC/Sigma Aldrich, USA, 5 µm, 150 x 4.6 mm), mobile 
phase A: 0.3 M methanol/TEAA (20/80, v/v), pH = 4, T=40°C.CSP II: Nucleodex β-OH (Macherey-Nagel, 
Germany, 5 µm, 200 x 4 mm), mobile phase: 0.05 M NH4Ac/acetonitrile (95/5, v/v), pH = 3, T=20°C. [173] 
 
Besides the selectivity also the loadabilities of the stationary phase are of large importance. 
Frequently the Langmuir adsorption isotherm model can be applied to describe the typically 




1       [Eq. 1] 
In this equation the c and q represent the concentrations in the fluid and adsorbed phases, 
respectively, qsat is the saturation capacity and b is a parameter describing the isotherm 
nonlinearity. Parameters of Eq.1, as determined by frontal analysis, are given in Table  4 for the 
two CSP applicable to separate the mandelic acid enantiomers.[250, 275-277] There, in addition two 
more mobile phases (Table 3) allowing for higher solubilities were considered. The isotherm 
parameters reveal that the different chromatographic systems are characterized by very 
different initial isotherm slopes, saturation capacities and separation factors. The table further 
further provides maximum concentrations cmax, which mark the range of applicability of the 
adsorption isotherm model and roughly limits of solubility as an important constraint in 
preparative chromatography. 
An optimization study was performed for the different chromatographic systems using this 
thermodynamic information as well as the numbers of theoretical plates provided by the specific 
columns in a standard dynamic model capable to predict the performance of a conventional 
chromatographic column operated in the batch mode.[216, 275, 276] In Fig. 26 are presented the 




































column close to the solubility limit. The highest performance is available with CSP I and the 
mobile phase A. This is essentially due to the highest separation factor provided by this system 
(α=1.40). Although mobile phase B provides a much higher solubility and with CSP I similar 
saturation capacities as system I.A the lower separation factor can not be compensated. 
Obviously, CSP II can not be considered as an alternative for solving this separation problem. 
 
Table 3: CSP and mobile phase compositions (v/v) used for the separation of the mandelic acid  
enantiomers.[275, 276] 
CSP Mobile Phase 
I A: MeOH:0.3M TEAAc (20/80), pH=4.02 
I B: EtOH:0.36M TEAAc (1/1), pH=6.56  
I C: MeOH:MeCN:TEAAc:HOAc (54.5/45/0.25/0.25) 
II MeCN:HOAc:0.05M AAc (4.5/9.1/86.4), pH=3.0 
  
 
MeOH – methanol, TEAAc – triethylammonium acetate, EtOH – ethanol, 
MeCN – acetonitrile, HOAc – acetic acid, AAc – ammonium acetate 
 
Table 4: Adsorption isotherm parameters and solubilities of the mandelic acid enantiomers for different 
chromatographic systems.[275-277] 
System Enan- T  qsat b α= (qsat b)R /( qsat b)S cmax 
 tiomer °C gL-1 Lg-1  gL-1 
I.A  R-(–)  40 77.8 0.0207 1.40 15 
 S-(+) 40 261.2 0.0044  15 
I.B  R-(–)  40 181.8 0.0064 1.14 55 
 S-(+) 40 178.3 0.0057  55 
I.C  R-(–)  40 155.1 0.0086 1.24 38 
 S-(+) 40 276.4 0.0039  38 
II R-(–)  20 70.6 0.1222 1.07 5 




Figure 26: Productivities of performing a chromatographic separation of racemic mandelic acid as a function of the 
injection concentration for the four chromatographic systems summarized in Tables 3and 4.[276]  
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c) Tröger’s base 
The separation of racemic Tröger’s base is a classical test problem in the field of 
chromatographic enantioseparation. The first successful separation using microcrystalline 
cellulose triacetate as the CSP was reported in 1973 by Hesse and Hagel.[278] Results of further 
systematic studies with this chiral compound characterized were published in [279]. The 
successful application of cellulose triacetate in a continuous 8 column SMB process was 
described in [280]. Later many other CSP were found capable to perform the separation. Results 
of screening polysaccharides and solvents as well as an optimization of loadability and 
productivity were described.[281] Successful chromatographic enantioseparations of 
functionalized derivatives of the Tröger’s base using various CSP were reported in [282-284]. 
First reports about unusual shapes of chromatographic peaks of the Tröger’s base enantiomers 
were published in [285, 286].In own work these strange peak forms were confirmed.[287] Fig. 27 
shows single component elution profiles of the two pure enantiomers of Tröger’s base for 
microcrystalline cellulose triacetate (CTA) as the stationary phase and pure ethanol as the 
mobile phase. Whereas in a series of overloading the column for the (-)-enantiomers the 
development of asymmetric peaks with an increasing tailing can be observed, the peak shapes 
of the (+)-enantiomers follow another trend. In the course of successive column overloading the 
elution profiles of (+)-Tröger’s base are characterized by an initial orientation of the peak 
maximum to longer retention times. Further overloading changes this trend and the orientation 
of the maximum turns to shorter retention times, as typical for Langmuirian system following Eq. 
1.[216] 
Systematic studies devoted to measure the adsorption isotherms of the two enantiomers using 
frontal analysis[250] revealed the more complex isotherm shape for the (+) enantiomer (Fig. 28). 
This isotherm is characterized by an inflection point located at a liquid phase concentration of 
about 0.5 gL-1. 
The isotherm measured for the (+)-enantiomer can only be described using more complex 
isotherm equations. The following quadratic equation arising from statistical thermodynamics 















Figure 27: Series of overloading a microcrystalline cellulose triacetate column with injections of the pure 
enantiomers of Tröger’s base. Mobile phase: ethanol. Flowrate: 0.5 ml min-1. Temperature: 20 °C. 
Injection concentration: 15 gL-1.Injection volumes: 10, 30, 90, 250µl.Left: (-)-Tröger’s base. Right: (+)-




Figure 28: Adsorption isotherms (top) at 20°C and corresponding chords (bottom) for the adsorption of the 






















































































































































































































































Applying a) the parameters derived in [289-291], b) the ideal adsorbed solution theory[292], which is 
capable to describe multicomponent adsorption equilibria for arbitrary shapes of the single 
component isotherms and c) the equilibrium dispersive model of a chromatographic column[216], 
elution profiles of Tröger’s base could be rather well represented for the single enantiomers 
(Fig. 27) and racemic mixtures (Fig. 29).[293] 
 
Figure 29: Measured and simulated chromatogram for the separation of the enantiomers of Tröger’s base under 
strongly overloaded conditions. Symbols: Experiment, lines: equilibrium dispersive model using within the 
ideal adsorption solution theory Eq.2. Flowrate 0.5 ml min-1, temperature: 20 °C, injection volumes: 1 µl, 
injection concentrations: 1.5 gL-1.[293] 
 
Further work regarding the thermodynamic characterization of this challenging chromatographic 
system and first attempts devoted to explain the behavior based on  molecular simulations are 
given in [294, 295]. 
Reports on successful continuous chromatographic separation of the Tröger’s base 




In order to carry out a comparative study, in [298] two CSP based on macrocyclic glycopeptides 
were applied for the separation of the enantiomers of methionine, namely teicoplanin (i.e. 
Chirobiotic T, ASTEC, USA) and eremomycin (i.e. Chirasel E, BioChemMack, Russia). The 
latter (M=1540 g*mol-1[299]) contains 22 chiral centers, three cavities, three sugar moieties, five 































In Fig. 30 are given the adsorption isotherms of the two methionine enantiomers at 25°C for 
these CSP and the corresponding mobile phases compositions indicated in the figure caption. 
The selectivities are significant and do not differ much for the two CSP. 
 
Figure 30: Adsorption isotherms at 25 °C of L- and D-methionine for Chirobiotic T (dotted) withEtOH:H2O=40/60 (v/v) 
and Chirasel E (line) with MeOH: H2O (0.1 M NaH2PO4)=20/80 (v/v).[298] 
 
Elution profiles were predicted using the isotherms shown in Fig. 30and the already mentioned 
equilibrium dispersive model. A typical result, shown in Fig. 31, demonstrates the applicability of 
both the adsorption isotherm and column models in order to describe the shape of elution 
profiles and to evaluate performance parameters. 
 
Figure 31: Experimental (symbols) and calculated (dotted) elution profiles of DL-methionine for the Chirasel E 
column, injection concentrations for both enantiomers: 6.1 gL-1, the first peak corresponds to L-
methionine.[298] 
 







































Fig. 32 summarizes the results of intensive numerical simulations performed with the validated 
model. For the applied lab scale batch column the influence of the amount injected on the 
product of productivity (PR) and recovery yield (RY) was evaluated. The figure clearly reveals 
the better performance of the Chirasel E CSP, and provides information about the most 
beneficial injection amounts. It can be also seen, that the performance of the chromatographic 
process is higher if the first eluting L-methionine is the target component. Based on this 
information classical scale up rules can be applied to predict optimal operating parameters for 
larger columns.[216] 
Because of the fact that Chirasel E performed better and appeared to be also more stable than 
Chirobiotic T, it was used in an experimental SMB study, where 8 connected conventional 
HPLC columns were used (each L=10 cm, d=0.46 cm). Feed-concentrations of up to 10 gL-1 
were applied, located in the nonlinear range of the adsorption isotherms. Successful continuous 
separation of the two methionine enantiomers was achieved after carefully designing the SMB 
process. The overall process productivity was evaluated to be appr. 0.75 kg kg-1CSPday-1.[300] 
 
Figure 32: Simulated dependence of Productivity (PR) times Recover Yield (RY) of L- (circles) and 
  D-methionine (triangles) on mass injected for 2 CSP (Chirobiotic T, EtOH/H2O=40/60 (v/v),  
  solid symbols; and Chirasel E, MeOH/H2O (0.1 M NaH2PO4)=20/80 (v/v), open symbols).  
  Specified purity requirements: 99%.[300] 
 
 
5. Coupling of chromatography and crystallization 
After introducing enantioselective crystallization and chromatography individually a 
straightforward and very promising concept will be described in this section based on combining 
these two techniques. The basic idea behind this coupling is the well-known fact, that any 
separation process loses performance, if the requirements regarding product purity are raised. 
Considering e.g. SMB chromatography, it is obvious that the process must be designed and 
operated much more careful and conservative if the purity of the streams leaving the 























corresponding unit must be very high, compared to a constellation in which lower purities are 
acceptable. In addition, compared to preparative chromatography, crystallization is a cheaper 
and in general simpler process. However, as discussed above, for racemic compound-forming 
systems successful application of standard enantioselective crystallization techniques requires 
the provision of a certain initial enrichment. Thus, a reasonable approach, suggested in [301-303], 
is to use the expensive chromatographic step to achieve, prior to crystallization, just the 
required start composition. Examples for such hybrid processes were recently investigated in a 
systematic manner within the European FP7-project INTENANT (INTegrated synthesis and 
purification of single ENANTiomers). This project was successful in exploring several 
possibilities of combining chemical and physical approaches capable to deliver pure 
enantiomers.[34] 
Within the INTENANT-project in a comprehensive case study a racemic mixture of bicalutamide, 
a drug substance used in the treatment of prostate cancer, was separated by simulated moving 
bed chromatography, with the objective of maximizing throughput at a reduced outlet purity[168]. 
Fig. 33 shows the structure of the target (R)-enantiomer. Currently bicalutamide is sold as a 
racemate. The isolation of the pure (R)-enantiomer from the pre-enriched mixture of 
bicalutamide enantiomers was successfully scaled up from laboratory experiments using only a 
few grams of material to a scale of 600 g of racemate. The throughput of the first SMB 
chromatography step using Chiralpak AD as the chiral stationary phase could be significantly 
increased due to setting a lower outlet purity. The fraction leaving the SMB extract port 
possessed a projected enrichment of 92:8 and was subjected to two subsequent crystallization 
steps as illustrated in Fig. 34. More details regarding the realized exploitation of the shift of the 
position of the eutectic composition in the bicalutamide phase diagram with temperature and 
addition of water as an anti-solvent are given elsewhere.[168] The two simple crystallization steps 
increased progressively the enantiomeric purity, and the final product was 99.99% pure. The 
experimentally determined yield was found to be 45%. 
In order to analyze and evaluate the potential of such hybrid chromatography-crystallization 
processes more systematically and efficiently reliable short-cut methods were developed 
recently.[275, 304, 305] A comparison of competing concepts is shown for the bicalutamide case in 
Fig. 35. The results show that the coupled process based on a “SMB transition purity” of 92% is 
capable of more than doubling the productivity of isolating the target (R)-enantiomer from a 
racemic solution compared to applying SMB chromatograph alone.[168] 
A more general analysis revealed, that the described type of a hybrid process is in particular 










Figure 34: Flowsheet of the coupled process realized in order to isolate (R)-bicalutamide (target enantiomer). The 
racemic feed mixture is first enriched by SMB chromatography (A) and further purified in two subsequent 
crystallization steps (B and C). Fractional recycling of the solid phase from (B) and the entire mother liquor from (C) 




Figure 35: Optimized (R)-bicalutamide productivities of the stand-alone SMB chromatographic process (right 
diamond marks productivity for 100% purity, upper solid line marks productivity for reduced purity). The gain in 
productivity for the coupled process compared to SMB alone is reflected by the dotted line (adopted from [168]). 
 
Similar results as for bicalutamide were obtained already earlier analyzing the separation of the 
enantiomers of mandelic acid using a Chirobiotic T column in combination with a crystallization 
process assumed to reach equilibrium conditions.[304] The reference case was again the 
exclusive application of SMB (100% purity). For this particular example an optimal transition 
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concentration between chromatography and crystallization of approximately 93% was 
determined, providing a performance increase (compared to SMB chromatography alone) of 
approximately 45%. 
Considering the separation of the enantiomers of Tröger’s base, a genetic algorithm was used 
in [191] to optimize the combined process, using proper definitions of objective functions. Multi-
objective optimization of productivity and evaporation cost in terms of essential operating 
parameters (column length and SMB feed concentration) shows for this coupled process an 
optimum SMB purity value as a trade-off between increased SMB performance and recycle of 
the mother liquor. Further examples devoted to study quantitatively combinations of 
chromatography and crystallization were reported in [306-308]. All the results summarized here 
clearly indicate that the combined process can achieve better performance than the SMB 
process alone. 
Alternative provision of an initial enrichment prior to crystallization was suggested recently in 
[309]. It is based on using an enantiomerically selective membrane within a pertraction process. 
Obviously, other combinations of different separation processes with subsequent crystallization 
are imaginable. 
A powerful and attractive alternative capable to provide initial enrichment for final crystallization 
is clearly the option of realizing a partially selective synthesis reaction. This approach was 
applied e.g. in[171, 310]. 
 
 
6. Process concepts considering racemization 
In living tissue, all amino acids have the L-configuration, but after the death of an organism a 
very slow racemization proceeds, which therefore can be used for dating.[311] 
In processes intended to provide pure enantiomers, in addition to the desired product fraction, 
typically a second fraction is produced, which is enriched in the “counter-enantiomer”. For 
economic reasons it is highly desirable to exploit also this side fraction. This can be done 
incorporating sufficiently fast racemization reactions. If these reactions are successful, the 
formed racemic mixtures can be reintroduced in the feed stream of a separation process or at 
another suitable position within the process sequence allowing an increase of the yield with 
respect to the target enantiomer. In the ideal case that no counter-enantiomer leaves the 
process, a yield of 100% is possible.  
To reuse “counter-enantiomers” there are numerous activities devoted to develop selective and 
sufficiently active racemization catalysts. Both chemical and enzymatic approaches are 




The general approach is discussed for the the combination of chromatographic separations with 
biotransformations e.g. in [313]. An overview providing recent examples of the combination of 
enantioselective HPLC, including SMB chromatography and racemization is given in [273].  
Referring to an example already discussed extensively above, interesting progress regarding 
the development of an efficient mandelate racemase is reported in [314]. In [315] a recombinant 
amino acid racemase which offers a broad substrate specificity was prepared from 
Pseudomonas putida cloned into Escherichia coli. Enzyme lyophilizates of different purity were 
applied in the racemization of methionine and asparagine in [155]. The racemase was further 
successfully used for in situ racemization during preferential crystallization of the enantiomers of 
asparagine. Crystallization experiments accompanied by enzymatic racemization led to a 
significant increase of crystallized L-asparagine.[122, 155] 
Within the mentioned INTENANT-project an integrated process for the separation of the 
enantiomers of the industrially relevant substance 2′,6′-pipecoloxylidide (PPX, Fig. 36) was 




Figure 36: Structure of (S)-pipecoloxylidide (PPX) and reaction scheme for racemization[169]. 
 
The integrated chiral resolution process developed combines chromatography, crystallization, 
and racemization. The flowsheet of the entire process is illustrated in Fig. 37. Preparative 
chromatography was used to obtain an enantioenriched solution from the initial racemic mixture 
of PPX. Despite the fact that the chromatographic separation employed provides unsatisfactory 
resolution when assessed in isolation, relaxed purity requirements lead to improved productivity, 
reduced eluent volumes, and an output stream sufficiently enriched for enantioselective 
crystallization. Crystallization in the 2-phase region could be then used to isolate the pure (S)-
PPX with a purity of ≥99.5%, while the remaining, enriched mother liquor is recycled into the 
chromatographic separation. The (R)-PPX-rich chromatography stream was then racemized 
using a homogeneous Ruthenium catalyst (Shvo-catalyst)[169, 312e], which provided efficiently a 
racemic mixture of PPX (Fig. 36), that could be recycled into the chromatography step together 
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with fresh feed. The presence of alcohols (isopropanol or ethanol) led to an undesired side 
reaction, which necessitated removing them out of the chromatography effluent prior to 
racemization by distillation. The rationally designed and successfully applied integrated process 
exploits dibutylether as a common basic solvent system and realizes a full recycling of all 
solvents and the undesired (R)-PPX. It could be experimentally validated on lab and pilot scale 
(gram and several 100 g, respectiviely) and provided both high productivity and yield.[169] 
 
 
Figure 37: Integrated process scheme to separate racemic PPX. Initially the racemic feed is enriched by 
chromatography. The resulting (S)-PPX-rich stream is after creating supersaturation subjected to crystallization. The 
mother liquor is returned to the chromatographic enrichment. The (R)-PPX-rich stream is racemized and then also 
returned to the chromatographic separation. The function of intermediate distillations is to adjust the solvent 
compositions.[169] 
 
Considering the large potential of the general approach, reports on industrial processes 
exploiting consequently racemization are still limited. This is probably partly also due to the fact, 
that there might occur problems with the formation of unwanted degradation products. The 
above mentioned and other promising results trigger currently intensive efforts devoted to 
incorporate more systematically racemization steps in various process chain devoted to 




Several possible concepts capable to separate enantiomers in a preparative manner have 
been described in this process oriented review demonstrating that the racemic approach 
provides a powerful alternative to enantioselective synthesis. 
Crystallization-based methods and preparative chromatography have been presented in more 
detail based on various case studies. Currently these methods appear to be most advanced. 
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The selection, design and optimization of crystallization techniques require knowledge 
regarding the underlying solid-liquid equilibria which has to be gathered experimentally. Based 
on the specific type of phase diagram the most productive mode of operation can be identified. 
Due to the availability of highly selective chiral stationary phases, preparative overloaded high 
performance liquid chromatography can be currently seen as the most versatile technique. The 
high pressure equipment required and the process complexities limit the applicability in larger 
scales. The breakthrough of the simulated moving bed technology contributes to further 
promoting chromatographic enantioseparation. 
As a very promising approach is seen the application of hybrid processes combining the 
positive features of several separation processes. Although these processes are more 
challenging, there are nowadays rules and short-cut methods for a rational design available. it 
was shown within the INTENANT project that the achievable overall productivity can be 
increased significantly by e.g. generating initially an enrichment using chromatography followed 
by highly selective crystallization processes. Based on the results obtained regarding the two 
case studies described (bicalutamide and PPX) and many further examples a helpful decision 
tree was suggested considering at first the economically crucial question whether a compound 




Figure 38: Decision tree based on simple qualitative criteria supporting a rational selection of a suitable process 
concept for the production of pure enantiomers.[based on 305] 
 
If racemization is possible, the knowledge of the phase diagram of the specific chiral system is 
most instructive to decide a) about the presence of a conglomerate and to evaluate afterwards 
b) the eutectic composition in the chiral system. As a result of this information different 
resolution strategies open up, which might be e.g. a possible combination of racemization with 
just crystallization (right branch in Fig. 38) or based on chromatographic enrichment and 
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subsequent crystallization steps as proposed for PPX (second branch from the right). In cases, 
where racemization is not successful, asymmetric synthesis might be economically most 
attractive, eventually combined with a subsequent final crystallization purification step. If both 
racemization and asymmetric synthesis are not feasible, e.g. chromatography and 
crystallization allows for resolution of such a racemate (left branch). 
For the future can be expected, that enantioselective separation processes will be increasingly 
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